Annexon Ownership | Who Owns Annexon?
Annexon Ownership Summary
Annexon is owned by 17.69% institutional investors, 0.57% insiders, and 81.75% retail investors. Fmr is the largest institutional shareholder, holding 10.17% of ANNX shares. BB Biotech AG Ord is the top mutual fund, with 4.84% of its assets in Annexon shares.
ANNX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Annexon | 17.69% | 0.57% | 81.75% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 14.22M | 10.17% | $72.97M |
Blackrock funding, inc. /de | 8.49M | 6.06% | $43.53M |
Blackrock | 6.59M | 5.37% | $32.28M |
Alerce investment management | 7.41M | 5.29% | $37.99M |
Bvf inc/il | 7.00M | 4.73% | $13.51M |
Redmile group | 6.30M | 4.25% | $12.16M |
Point72 asset management | 5.63M | 4.02% | $28.87M |
Vanguard group | 5.55M | 3.96% | $28.46M |
Bellevue group | 5.16M | 3.69% | $26.46M |
Bain capital life sciences investors | 5.25M | 3.54% | $10.13M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Alerce investment management | 7.41M | 66.89% | $37.99M |
Sio capital management | 3.40M | 1.95% | $6.56M |
Logos global management lp | 2.55M | 1.53% | $13.08M |
Bain capital life sciences investors | 5.25M | 1.50% | $10.13M |
Tfg asset management gp | 2.65M | 1.17% | $5.11M |
Sphera funds management | 1.24M | 1.15% | $6.38M |
Redmile group | 6.30M | 1.15% | $12.16M |
Bvf inc/il | 7.00M | 0.55% | $13.51M |
Bellevue group | 5.16M | 0.51% | $26.46M |
Ghost tree capital | 214.50K | 0.33% | $1.05M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fmr | 14.22M | 0.00% | 5.66M |
Blackrock | 6.59M | 0.00% | 1.54M |
Tfg asset management gp | 2.65M | 1.17% | 1.25M |
Sphera funds management | 1.24M | 1.15% | 1.24M |
Sio capital management | 3.40M | 1.95% | 1.03M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Adage capital partners gp | - | - | -2.84M |
Gmt capital | - | - | -1.91M |
Pictet asset management sa | - | - | -1.64M |
Eventide asset management | - | - | -1.02M |
Polar capital | - | - | -1.00M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Sphera funds management | 1.24M | 1.15% | 1.24M | $6.38M |
Ghost tree capital | 214.50K | 0.33% | 214.50K | $1.05M |
J. safra sarasin | 155.74K | 0.01% | 155.74K | $798.97K |
Swiss national bank | 135.00K | 0.00% | 135.00K | $692.55K |
Lmr partners llp | 120.00K | 0.01% | 120.00K | $588.00K |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -2.00 |
Nelson, van denburg & campbell wealth management group | -9.00 |
Quadrant capital group | -34.00 |
Lindbrook capital | -83.00 |
Smartleaf asset management | -119.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 10 | -93.59% | 26,197,503 | -76.64% | 17 | 0.28% | 4 | -95.51% | - | -100.00% |
Dec 31, 2024 | 155 | 6.16% | 112,163,548 | 1.74% | 80 | 1.29% | 88 | 10.00% | 38 | 2.70% |
Sep 30, 2024 | 146 | -7.01% | 110,248,434 | 2.42% | 78 | 1.02% | 80 | -18.37% | 37 | 15.63% |
Jun 30, 2024 | 157 | 16.30% | 107,640,091 | 13.59% | 87 | 1.47% | 98 | 22.50% | 32 | 14.29% |
Mar 31, 2024 | 135 | 32.35% | 94,758,161 | 17.52% | 77 | 0.73% | 80 | 42.86% | 28 | 3.70% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
BB Biotech AG Ord | 5.16M | 4.84% | - |
Fidelity Growth Compy Commingled Pl S | 4.14M | 3.77% | - |
Vanguard Total Stock Mkt Idx Inv | 3.01M | 2.74% | - |
Fidelity Growth Company Fund | 2.98M | 2.72% | - |
Vanguard US Total Market Shares ETF | 2.83M | 2.58% | - |
Candriam Eqs L Biotech C USD Cap | 2.53M | 2.31% | - |
iShares Russell 2000 ETF | 2.50M | 2.28% | 1.23K |
Fidelity Growth Compy Commingled Pl O | 2.37M | 2.25% | - |
SPDR® S&P Biotech ETF | 2.32M | 2.11% | -14.13K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.38M | 1.26% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 18, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell | $16.34K |
Feb 18, 2025 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | Sell | $16.38K |
Feb 18, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | $24.28K |
Feb 18, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | $19.52K |
Feb 18, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | $20.18K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 9 |
2024 Q4 | 2 | 1 |
2024 Q3 | 3 | 7 |
2024 Q2 | 3 | - |
2024 Q1 | - | 7 |
ANNX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools